Bevacizumab plus temozolomide: a novel treatment option for advanced neuroendocrine tumors?
J Clin Oncol
.
2013 Mar 1;31(7):975-6.
doi: 10.1200/JCO.2012.45.7523.
Epub 2013 Jan 28.
Authors
Anna Koumarianou
,
Gregory Kaltsas
PMID:
23358970
DOI:
10.1200/JCO.2012.45.7523
No abstract available
Publication types
Letter
Comment
MeSH terms
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Dacarbazine / administration & dosage*
Dacarbazine / analogs & derivatives*
Female
Humans
Male
Neuroendocrine Tumors / drug therapy*
Substances
Dacarbazine